SCHEMBL1502327

SCHEMBL1502327

CC(=O)Oc1ccc2ccccc2c1C(=O)O

nearest known ligand 0.57

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
NCEH1 Q6PIU2 8/20 0.57
KDM4E B2RXH2 4/20 0.50
HSD17B10 Q99714 3/20 0.50
ALDH1A1 P00352 3/20 0.50
HPGD P15428 2/20 0.50
CYP1A2 P05177 2/20 0.50
TSHR P16473 2/20 0.50
ESR1 P03372 1/20 0.50
ITGB3 P05106 1/20 0.50
ITGA2B P08514 1/20 0.50
HMGB1 P09429 1/20 0.50
GGT1 P19440 1/20 0.50
PTGS1 P23219 1/20 0.50
PTGS2 P35354 1/20 0.50
BLM P54132 1/20 0.50
NAPRT Q6XQN6 1/20 0.50
TDP1 Q9NUW8 1/20 0.50
MEN1 O00255 1/20 0.50
GLA P06280 1/20 0.50
CYP2C19 P33261 1/20 0.50

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL536406 0.98 NCEH1 (0.56) NCEH1KDM4EHSD17B10ALDH1A1HPGD
SCHEMBL9702459 0.88 NCEH1 (0.47) NCEH1KDM4EHSD17B10ALDH1A1HPGD
SCHEMBL23930399 0.88 NCEH1 (0.72) NCEH1KDM4EHSD17B10ALDH1A1HPGD
Zinc Ion SCHEMBL536405 0.84 NCEH1 (0.55) NCEH1KDM4EHSD17B10ALDH1A1HPGD
SCHEMBL979842 0.83 CA12 (0.58) NCEH1KDM4EHSD17B10ALDH1A1HPGD
SCHEMBL8761945 0.82 KDM4E (0.58) NCEH1KDM4EHSD17B10ALDH1A1HPGD
Hydrochloric Acid SCHEMBL5403782 0.81 CA12 (0.56) NCEH1KDM4EHSD17B10ALDH1A1HPGD
SCHEMBL12199931 0.81 MAPT (0.58) NCEH1KDM4EHSD17B10ALDH1A1HPGD
SCHEMBL30710587 0.81 MAPT (0.58) NCEH1KDM4EHSD17B10ALDH1A1HPGD
SCHEMBL10334136 0.81 NCEH1 (0.71) NCEH1KDM4EHSD17B10ALDH1A1HPGD

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 68 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20080091043-A1 PROCESS FOR PREPARING AN ORGANIC ACID OR ITS DERIVATIVES USING A HOMOGENEOUS MC-TYPE CATALYST AND AN O2/CO2 MIXTURE KOCAT INC. (KR) 2008-04-17 US claimed
EP-1911737-A1 Process for preparing an organic acid or its derivatives using a homogeneous MC-Type catalyst an O2/CO2 mixture Kocat Inc. (KR) 2008-04-16 EP claimed
WO-2000027787-A1 METHOD OF PRODUCING ACETOXYARYL CARBOXYLIC ACIDS EASTMAN CHEMICAL COMPANY (US) 2000-05-18 WO claimed
US-5439541-A Combining at least one oligomer having carboxylic acid end groups with at least one oligomer having ester end groups, where at least one of the oligomers is branched; applying; curing THE BOARD OF TRUSTEES OF THE UNIVERSITY OF ILLINOIS (US) 1995-08-08 US claimed
US-8993799-B2 Method for producing a purified naphthalene dicarboxylic acid MITSUBISHI GAS CHEMICAL COMPANY, INC. (JP) 2015-03-31 US disclosed
US-8780558-B2 Porous thermoplastic foams as heat transfer materials UNIVERSITY OF WASHINGTON THROUGH ITS CENTER FOR COMMERCIALIZATION (US) 2014-07-15 US disclosed
US-8420396-B2 For delivering DNA/RNA into cells SANOFI-AVENTIS DEUTSCHLAND GMBH (DE) 2013-04-16 US disclosed
US-8354359-B2 Heat-sensitive adhesive agent and heat-sensitive adhesive sheet RICOH COMPANY, LTD. (JP) 2013-01-15 US disclosed
US-8324405-B2 Chromene derivatives and use thereof as HIF hydroxylase activity inhibitors FIBROGEN, INC. (US) 2012-12-04 US disclosed
US-20120195004-A1 Porous Thermoplastic Foams as Heat Transfer Materials UNIVERSITY OF WASHINGTON (US) 2012-08-02 US disclosed
WO-2011028924-A2 POROUS THERMOPLASTIC FOAMS AS HEAT TRANSFER MATERIALS UNIVERSITY OF WASHINGTON (US) 2011-03-10 WO disclosed
US-20100331400-A1 CHROMENE DERIVATIVES AND USE THEREOF AS HIF HYDROXYLASE ACTIVITY INHIBITORS FIBROGEN, INC. 2010-12-30 US disclosed
EP-0276915-A1 Thermotropic polymer compositions IMPERIAL CHEMICAL INDUSTRIES PLC (GB) 1988-08-03 EP disclosed
EP-0275163-A2 Dispersion polymerisation process IMPERIAL CHEMICAL INDUSTRIES PLC (GB) 1988-07-20 EP disclosed
EP-0275164-A2 Thermotropic aromatic copolyester HOECHST CELANESE CORPORATION (US) 1988-07-20 EP disclosed
EP-0081900-B1 ANISOTROPIC POLYMERS HAVING IMPROVED RETENTION OF PHYSICAL PROPERTIES AT ELEVATED TEMPERATURES AND METHODS OF MANUFACTURE THEREOF IMPERIAL CHEMICAL INDUSTRIES PLC (GB) 1987-05-13 EP disclosed
EP-0188120-A2 Moulding process NATIONAL RESEARCH DEVELOPMENT CORPORATION (GB) 1986-07-23 EP disclosed
US-4499256-A Anisotropic polyesteramide polymers having improved retention of physical properties at elevated temperatures and methods of manufacture thereof IMPERIAL CHEMICAL INDUSTRIES PLC (GB) 1985-02-12 US disclosed
EP-0081900-A1 Anisotropic polymers having improved retention of physical properties at elevated temperatures and methods of manufacture thereof IMPERIAL CHEMICAL INDUSTRIES PLC (GB) 1983-06-22 EP disclosed
US-4145443-A HYPOTENSIVE SYNTEX (U.S.A.) INC. (US) 1979-03-20 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20100331400-A1 CHROMENE DERIVATIVES AND USE THEREOF AS HIF HYDROXYLASE ACTIVITY INHIBITORS HIF1AN, HIF1A, EGLN2 NCEH1 247/4885KDM4E 550/4885HSD17B10 93/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.